Publications by authors named "Wim Mol"

Claim this Profile
A
A Diversity Covering (DiCo) Plasmodium vivax apical membrane antigen-1 vaccine adjuvanted with RFASE/RSL10 yields high levels of growth-inhibitory antibodies.
Bart W Faber, Lee M Yeoh, Liriye Kurtovic, Wim E M Mol, Martin Poelert

Vaccine· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody.
Tamara Mateu-Albero, Raquel Juárez-Sánchez, Javier Loscertales, Wim Mol, Fernando Terrón

Cancer Immunol Immunother· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL.
Carlos Cuesta-Mateos, Raquel Juárez-Sánchez, Tamara Mateu-Albero, Javier Loscertales, Wim Mol

MAbs· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antifungal Prophylaxis After Lung Transplantation: Where Are We Now?
Wim De Mol, Saskia Bos, Hanne Beeckmans, Katrien Lagrou, Isabel Spriet

Transplantation· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis